Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06502353 · ClinicalTrials.gov registry record · NA
Plexaa For Preconditioning: Gender Affirming Mastectomy
A NA study of Nipple Necrosis and Nipple Graft Loss, sponsored by Plexaa.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06502353 is a NA study of Nipple Necrosis and Nipple Graft Loss that is actively recruiting participants, run by Plexaa. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06502353, a NA study of Nipple Necrosis and Nipple Graft Loss, is actively recruiting participants, sponsored by Plexaa.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy. This study aims to understand a participant's experience of the device, including its usability and acceptability. Participants will use the device to precondition their right breast the evening before undergoing surgery (gender affirming mastectomy).
Conditions Studied
Interventions
- DEVICE BLOOM43
Study Locations (1)
California
- Division of Plastic & Reconstructive Surgery, Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06502353
The ClinicalTrials.gov registry entry for NCT06502353 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Plexaa, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nipple Necrosis appearing as the primary indexed condition, and to 1 intervention - of which BLOOM43 is the first listed.
NCT06502353 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06502353 about?
NCT06502353 is a clinical study titled "Plexaa For Preconditioning: Gender Affirming Mastectomy". The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy. This study aims to understand a participant's experience of the device, including its usability and acceptability. Par...
What is the current status of trial NCT06502353?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-08-20. Estimated completion is 2026-06-01.
What conditions does trial NCT06502353 study?
This clinical trial studies the following conditions: Nipple Necrosis, Nipple Graft Loss.
What interventions are being tested in trial NCT06502353?
The interventions under investigation include: BLOOM43 (DEVICE).
Who is sponsoring clinical trial NCT06502353?
This trial is sponsored by Plexaa, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06502353 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.